FDA Investigator Antonetta M Colacchio
Antonetta M Colacchio has conducted inspections on 55 sites in 1 countries as of 02 Jul 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
55
Last Inspection Date:
02 Jul 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Antonetta M Colacchio:
Alex T Goodman,
Amy L Mccarthy,
Andrea J Schmidt,
Andrew J Gonzales,
Andrew M Kolenc,
Aryonna M Renouf,
Ashleigh P Barkans,
Ashleigh P Wodushek,
Azotearc,
Barbara J Rincon,
Bearde,
Betty Kay Baxter,
Bodenw,
Brandon K Lawson,
Brent W Higgs,
Bruce W Benware,
Carla J Lundi,
Carmen Ramirez,
Cheryl D Mccall,
Ciara J Bajulai Austin,
David A Gonzalez,
Debra L Curtis,
Edith M Gonzalez,
Elisa J Beard,
Elvin R Smith,
Eric R Holm,
Erica R Woody,
Felix J Marrero,
Frank L Cordova,
Garciam,
Gary C Pecic, Jr,
Hanna L Potter,
Harry A Wilson,
Howard A Webley,
Isaiah D Isakson,
James D Romero,
James P Stallings,
Jamie L Dion,
Jamie L Port,
Jennifer A Baker,
Jennifer L Wolfe,
Jennifer M Pouget,
Jennifer R Mathern,
John A Daubenspeck,
Joshua C Schafer,
Kamara Co,
Kathleen S Tormey,
Kathryn M Mogen,
Keely G Martin,
Keith C Littrell,
Kenneth S Boehnen,
Khumo A Phake,
Kristen E Szenderski,
Laura A Munsterman,
Laura B Kennedy,
Lavender M Huskey,
Lucas B Leake,
M Ibrahim Ali,
Manuel A Moreno,
Marc A Jackson, Jr,
Matthew J Hansen,
Michael L Zimmerman,
Michelle D Motsinger,
Mikayla K Turner,
Moonn,
Myers,
Nathan M Jornod,
Nathan R Moon,
Oluwaseyi Ojinni,
Patricia A Maestas,
Paul Z Balcer,
Randy V Bong,
Rebecca S Secrist,
Richard T Jensen,
Samantha E Rafferty,
Sandra I Huff,
Sara Jdent Acosta,
Shererk,
Solomon G Williams,
Steven O Gauthier,
Thaddeus M Steinke,
Thanh M Andrews,
Timothy T Kapsala,
Trushani T Desai,
Zachary L Miller
Antonetta M Colacchio's Documents
Publish Date | Document Type | Title |
---|---|---|
November, 2022 | EIR | Kasel Associates Industries, Inc. - EIR, 2022-11-28 |
November, 2023 | FDA 483 | Agfinity Inc - Form 483, 2023-11-30 |
August, 2022 | EIR | Covetrus North America LLC. - EIR, 2022-08-29 |
September, 2023 | FDA 483 | The Ziegenfelder Company, LLC - Form 483, 2023-09-01 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more